739 related articles for article (PubMed ID: 17582159)
1. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis.
Jayne DR; Gaskin G; Rasmussen N; Abramowicz D; Ferrario F; Guillevin L; Mirapeix E; Savage CO; Sinico RA; Stegeman CA; Westman KW; van der Woude FJ; de Lind van Wijngaarden RA; Pusey CD;
J Am Soc Nephrol; 2007 Jul; 18(7):2180-8. PubMed ID: 17582159
[TBL] [Abstract][Full Text] [Related]
2. Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement.
de Lind van Wijngaarden RA; Hauer HA; Wolterbeek R; Jayne DR; Gaskin G; Rasmussen N; Noël LH; Ferrario F; Waldherr R; Hagen EC; Bruijn JA; Bajema IM
J Am Soc Nephrol; 2006 Aug; 17(8):2264-74. PubMed ID: 16825335
[TBL] [Abstract][Full Text] [Related]
3. Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis.
de Lind van Wijngaarden RA; Hauer HA; Wolterbeek R; Jayne DR; Gaskin G; Rasmussen N; Noël LH; Ferrario F; Waldherr R; Bruijn JA; Bajema IM; Hagen EC; Pusey CD;
J Am Soc Nephrol; 2007 Jul; 18(7):2189-97. PubMed ID: 17596637
[TBL] [Abstract][Full Text] [Related]
4. ANCA-associated renal vasculitis at the end of the twentieth century--a disease of older patients.
Harper L; Savage CO
Rheumatology (Oxford); 2005 Apr; 44(4):495-501. PubMed ID: 15613403
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear.
Walsh M; Casian A; Flossmann O; Westman K; Höglund P; Pusey C; Jayne DR;
Kidney Int; 2013 Aug; 84(2):397-402. PubMed ID: 23615499
[TBL] [Abstract][Full Text] [Related]
6. Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis.
Neumann I; Kain R; Regele H; Soleiman A; Kandutsch S; Meisl FT
Nephrol Dial Transplant; 2005 Jan; 20(1):96-104. PubMed ID: 15546891
[TBL] [Abstract][Full Text] [Related]
7. Treatment with cytapheresis for antineutrophil cytoplasmic antibody-associated renal vasculitis and its effect on anti-inflammatory factors.
Hasegawa M; Watanabe A; Takahashi H; Takahashi K; Kasugai M; Kawamura N; Kushimoto H; Murakami K; Tomita M; Nabeshima K; Oohashi A; Kondou F; Ooshima H; Hiki Y; Sugiyama S
Ther Apher Dial; 2005 Aug; 9(4):297-302. PubMed ID: 16076370
[TBL] [Abstract][Full Text] [Related]
8. Recurrence of anti-neutrophil cytoplasmic antibody vasculitis in the kidney allograft.
Lau D; Summers S; Amos L; Simpson I; Mulley W
Nephrology (Carlton); 2012 Apr; 17 Suppl 1():16-9. PubMed ID: 22497649
[TBL] [Abstract][Full Text] [Related]
9. Predictors for outcomes in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation: a study of 89 cases in a single Chinese center.
Li ZY; Gou SJ; Chen M; Zhao MH
Semin Arthritis Rheum; 2013 Apr; 42(5):515-21. PubMed ID: 23332902
[TBL] [Abstract][Full Text] [Related]
10. Optimizing the therapeutic strategies in ANCA-associated vasculitis--single centre experience with international randomized trials.
Vanková Z; Ríhová Z; Jancová E; Rysavá R; Merta M; Tesar V
Prague Med Rep; 2006; 107(2):199-212. PubMed ID: 17066740
[TBL] [Abstract][Full Text] [Related]
11. [Kidney involvement in systemic necrotizing vasculitis].
Chauveau D; Guittard J; Mehrenberger M; Pourrat J
Rev Prat; 2008 Mar; 58(5):499-506. PubMed ID: 18524106
[TBL] [Abstract][Full Text] [Related]
12. Aggressive treatment with pulse methylprednisolone or plasma exchange is justified in rapidly progressive glomerulonephritis.
Stevens ME; McConnell M; Bone JM
Proc Eur Dial Transplant Assoc; 1983; 19():724-31. PubMed ID: 6878261
[TBL] [Abstract][Full Text] [Related]
13. [Rapidly progressive glomerulonephritis in a 68-year-old man].
Rubio E; Acevedo M
Nefrologia; 2004; 24 Suppl 3():101-4. PubMed ID: 15219081
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary renal syndrome: a 4-year, single-center experience.
Gallagher H; Kwan JT; Jayne DR
Am J Kidney Dis; 2002 Jan; 39(1):42-7. PubMed ID: 11774100
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive therapy and clinical evolution in forty-nine patients with antineutrophil cytoplasmic antibody-associated glomerulonephritis.
Kokolina E; Alexopoulos E; Dimitriadis C; Vainas A; Giamalis P; Papagianni A; Ekonomidou D; Memmos D
Ann N Y Acad Sci; 2005 Jun; 1051():597-605. PubMed ID: 16127000
[TBL] [Abstract][Full Text] [Related]
16. The impact of intravenous methylprednisolone pulses on renal survival in anti-neutrophil cytoplasmic antibody associated vasculitis with severe renal injury patients: a retrospective study.
Ma Y; Han F; Chen L; Wang H; Han H; Yu B; Xu Y; Chen J
BMC Nephrol; 2017 Dec; 18(1):381. PubMed ID: 29287586
[TBL] [Abstract][Full Text] [Related]
17. Urine IgM excretion predicts outcome in ANCA-associated renal vasculitis.
Bakoush O; Segelmark M; Torffvit O; Ohlsson S; Tencer J
Nephrol Dial Transplant; 2006 May; 21(5):1263-9. PubMed ID: 16449276
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane.
Lindic J; Vizjak A; Ferluga D; Kovac D; Ales A; Kveder R; Ponikvar R; Bren A
Ther Apher Dial; 2009 Aug; 13(4):278-81. PubMed ID: 19695059
[TBL] [Abstract][Full Text] [Related]
19. Plasmapheresis in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
Gaskin G; Pusey CD
Ther Apher; 2001 Jun; 5(3):176-81. PubMed ID: 11467753
[TBL] [Abstract][Full Text] [Related]
20. Improved survival in lupus nephritis in the modern era (1979 - 1989).
Mc'Ligeyo SO; Cameron SJ; Williams GD; Ogg C; Hartley RB; Chantler C; Haycock GB; Sacks S; Rigden R; Hicks JA
Afr J Health Sci; 1995 Feb; 2(1):211-219. PubMed ID: 12160446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
